Results 31 to 40 of about 79,532,914 (276)
Bothersome Hematospermia Following Stereotactic Body Radiation Therapy for Prostate Cancer
Frontiers in Oncology, 2021 BackgroundHematospermia following prostate radiation therapy is a benign and often self-limiting side effect. However, it may be bothersome to some men and their partners with a negative impact on sexual quality of life (QOL).
Sarthak Shah +7 more
doaj +1 more source
, 2020 This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of 5-alpha-reductase inhibitors (5ARIs) for treating lower urinary tract symptoms (LUTS) secondary to benign prostatic obstruction (BPO ...
Tacklind, James +2 more
core +1 more source
Effect of 5-alpha Reductase Inhibitor on Storage Symptoms in Patients with Benign Prostatic Hyperplasia [PDF]
International Neurourology Journal, 2011 Purpose Many patients with benign prostatic hyperplasia (BPH) have storage symptoms. The aim of this study was to evaluate the effects of treatment with a 5-alpha reductase inhibitor (5ARI) on storage symptoms in patients with BPH. Methods This study was
Kang Jun Cho +4 more
doaj +1 more source
Structure based design and synthesis of antiparasitic pyrrolopyrimidines targeting pteridine reductase 1 [PDF]
, 2014 The treatment of Human African Trypanosomiasis remains a major unmet health need in sub-Saharan Africa. Approaches involving new molecular targets are important and pteridine reductase 1 (PTR1), an enzyme that reduces dihydrobiopterin in Trypanosoma spp.
Kirsten Stewart +26 more
core +1 more source
Revista Médica Clínica Las Condes, 2023 Resumen: Introducción: La alopecia frontal fibrosante (AFF) es una alopecia linfocítica primaria cicatricial, cuya patogenia se desconoce. Se han desarrollado distintos regímenes de tratamientos farmacológicos, siendo el finasteride por sí sólo o en ...
Néstor Carreño-Orellana +3 more
doaj +1 more source
, 2015 The 5-year Cumulative incidence of cardiovascular diseases in those receiving and not receiving 5-alpha reductase inhibitors.
Tien-Huang Lin (631773) +8 more
core +1 more source
Management of benign prostate hyperplasia (BPH) by combinatorial approach using alpha-1-adrenergic antagonists and 5-alpha-reductase inhibitors. [PDF]
, 2020 Currently, the main available treatments for benign prostate hyperplasia (BPH) are alpha-1 adrenergic receptor antagonists (ARAs), 5-alpha reductase inhibitors (5-αRI), anticholinergics, and Phosphodiesterase-5 inhibitors.
Mohammad R. Hamad +5 more
core +1 more source
Inhibition of sterol biosynthesis in animal cells by 14 alpha-hydroxymethyl sterols.
Journal of Lipid Research, 1980 The chemical syntheses of a number of 14 alpha-hydroxymethyl sterols and 14 alpha -hydroxymethyl-15 alpha-hydroxysterols and their derivatives have been pursued to permit evaluation of their activity in the inhibition of sterol biosynthesis in animal ...
G J Schroepfer, Jr +3 more
doaj +1 more source
, 2015 SD, Standard deviation. ANGII, Angiotensin II Inhibitors. CCI, Charlson weighted comorbidity index. TURP, Transurethral resection of prostateBaseline characteristics for men exposed to 5 alpha reductase inhibitors (5-ARI) and selected non exposed men.
David Robinson (73947) +3 more
core +1 more source
, 2015 Kaplan-Meier failure curves of developing cardiovascular diseases in the patients receiving and not receiving 5-alpha reductase inhibitors.
Tien-Huang Lin (631773) +8 more
core +1 more source